nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—Hallucination, visual—Cyclosporine—focal segmental glomerulosclerosis	0.0402	0.0989	CcSEcCtD
Bromocriptine—HTR2A—arteriole—focal segmental glomerulosclerosis	0.0196	0.332	CbGeAlD
Bromocriptine—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.0172	0.0424	CcSEcCtD
Bromocriptine—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.0157	0.0386	CcSEcCtD
Bromocriptine—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.0151	0.0372	CcSEcCtD
Bromocriptine—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.0131	0.0321	CcSEcCtD
Bromocriptine—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.0101	0.0249	CcSEcCtD
Bromocriptine—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.0101	0.0249	CcSEcCtD
Bromocriptine—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00964	0.0237	CcSEcCtD
Bromocriptine—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00876	0.0215	CcSEcCtD
Bromocriptine—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00804	0.0198	CcSEcCtD
Bromocriptine—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0078	0.0192	CcSEcCtD
Bromocriptine—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00777	0.0191	CcSEcCtD
Bromocriptine—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00756	0.0186	CcSEcCtD
Bromocriptine—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00696	0.0171	CcSEcCtD
Bromocriptine—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00686	0.0169	CcSEcCtD
Bromocriptine—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00658	0.0162	CcSEcCtD
Bromocriptine—HTR7—endothelium—focal segmental glomerulosclerosis	0.00645	0.109	CbGeAlD
Bromocriptine—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00631	0.0155	CcSEcCtD
Bromocriptine—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00608	0.015	CcSEcCtD
Bromocriptine—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00579	0.0142	CcSEcCtD
Bromocriptine—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00575	0.0142	CcSEcCtD
Bromocriptine—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00551	0.0136	CcSEcCtD
Bromocriptine—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00528	0.013	CcSEcCtD
Bromocriptine—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00524	0.0129	CcSEcCtD
Bromocriptine—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00518	0.0127	CcSEcCtD
Bromocriptine—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00508	0.0125	CcSEcCtD
Bromocriptine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00491	0.0121	CcSEcCtD
Bromocriptine—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00478	0.0118	CcSEcCtD
Bromocriptine—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00475	0.0117	CcSEcCtD
Bromocriptine—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00471	0.0116	CcSEcCtD
Bromocriptine—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00466	0.0115	CcSEcCtD
Bromocriptine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00462	0.0114	CcSEcCtD
Bromocriptine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.0045	0.0111	CcSEcCtD
Bromocriptine—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00449	0.0111	CcSEcCtD
Bromocriptine—ADRA1B—kidney—focal segmental glomerulosclerosis	0.00446	0.0755	CbGeAlD
Bromocriptine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00445	0.011	CcSEcCtD
Bromocriptine—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00441	0.0109	CcSEcCtD
Bromocriptine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00432	0.0106	CcSEcCtD
Bromocriptine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00421	0.0104	CcSEcCtD
Bromocriptine—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00412	0.0101	CcSEcCtD
Bromocriptine—HTR2A—endothelium—focal segmental glomerulosclerosis	0.00402	0.0681	CbGeAlD
Bromocriptine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00397	0.00978	CcSEcCtD
Bromocriptine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00396	0.00975	CcSEcCtD
Bromocriptine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00389	0.00958	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00388	0.00954	CcSEcCtD
Bromocriptine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00382	0.0094	CcSEcCtD
Bromocriptine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00377	0.00929	CcSEcCtD
Bromocriptine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00374	0.00921	CcSEcCtD
Bromocriptine—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00372	0.00915	CcSEcCtD
Bromocriptine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00367	0.00903	CcSEcCtD
Bromocriptine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00364	0.00895	CcSEcCtD
Bromocriptine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00357	0.00878	CcSEcCtD
Bromocriptine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00339	0.00833	CcSEcCtD
Bromocriptine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00336	0.00827	CcSEcCtD
Bromocriptine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00334	0.00821	CcSEcCtD
Bromocriptine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00333	0.00819	CcSEcCtD
Bromocriptine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.0033	0.00811	CcSEcCtD
Bromocriptine—HTR1D—kidney—focal segmental glomerulosclerosis	0.00326	0.0552	CbGeAlD
Bromocriptine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00325	0.00801	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00323	0.00795	CcSEcCtD
Bromocriptine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00323	0.00794	CcSEcCtD
Bromocriptine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.0032	0.00788	CcSEcCtD
Bromocriptine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00308	0.00759	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00306	0.00753	CcSEcCtD
Bromocriptine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00297	0.00732	CcSEcCtD
Bromocriptine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00296	0.00728	CcSEcCtD
Bromocriptine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00296	0.00728	CcSEcCtD
Bromocriptine—HTR2B—cortex of kidney—focal segmental glomerulosclerosis	0.00295	0.05	CbGeAlD
Bromocriptine—ADRA2C—nephron tubule—focal segmental glomerulosclerosis	0.00271	0.046	CbGeAlD
Bromocriptine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00269	0.00661	CcSEcCtD
Bromocriptine—HTR7—kidney—focal segmental glomerulosclerosis	0.0026	0.044	CbGeAlD
Bromocriptine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00256	0.0063	CcSEcCtD
Bromocriptine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00248	0.00609	CcSEcCtD
Bromocriptine—ADRA2C—kidney—focal segmental glomerulosclerosis	0.00239	0.0404	CbGeAlD
Bromocriptine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00238	0.00586	CcSEcCtD
Bromocriptine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.00581	CcSEcCtD
Bromocriptine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.0058	CcSEcCtD
Bromocriptine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00235	0.00577	CcSEcCtD
Bromocriptine—ADRA2C—cortex of kidney—focal segmental glomerulosclerosis	0.00232	0.0394	CbGeAlD
Bromocriptine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.00547	CcSEcCtD
Bromocriptine—ADRA2A—cortex of kidney—focal segmental glomerulosclerosis	0.00185	0.0314	CbGeAlD
Bromocriptine—HTR2A—kidney—focal segmental glomerulosclerosis	0.00162	0.0274	CbGeAlD
Bromocriptine—CYP3A4—kidney—focal segmental glomerulosclerosis	0.0015	0.0254	CbGeAlD
Bromocriptine—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.00121	0.0204	CbGeAlD
Bromocriptine—ABCB1—kidney—focal segmental glomerulosclerosis	0.00106	0.018	CbGeAlD
Bromocriptine—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.00103	0.0175	CbGeAlD
Bromocriptine—DRD2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000216	0.000404	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000216	0.000403	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000215	0.000402	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000215	0.000402	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000215	0.000402	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000215	0.000401	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000214	0.0004	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000213	0.000399	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000213	0.000399	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000213	0.000398	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000212	0.000397	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000212	0.000397	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000211	0.000396	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000211	0.000395	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000211	0.000395	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000208	0.000389	CbGpPWpGaD
Bromocriptine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000205	0.000383	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000204	0.000382	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000203	0.00038	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000199	0.000373	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000198	0.00037	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000197	0.000369	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000197	0.000368	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000197	0.000368	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000197	0.000368	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000196	0.000367	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000196	0.000367	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000196	0.000366	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000196	0.000366	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000195	0.000365	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000195	0.000364	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000194	0.000364	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000194	0.000363	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000194	0.000363	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000194	0.000362	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000193	0.000362	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000193	0.00036	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000191	0.000358	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000191	0.000357	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00019	0.000356	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00019	0.000356	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00019	0.000356	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00019	0.000355	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000189	0.000354	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000189	0.000353	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000188	0.000351	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000187	0.000351	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000186	0.000349	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000185	0.000346	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000182	0.000341	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000181	0.000339	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00018	0.000337	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00018	0.000337	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000179	0.000335	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000179	0.000335	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000179	0.000335	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000179	0.000335	CbGpPWpGaD
Bromocriptine—ADRA2B—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000179	0.000335	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000178	0.000334	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000178	0.000332	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000177	0.000331	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000176	0.00033	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000176	0.00033	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000176	0.000329	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000175	0.000328	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000175	0.000328	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000174	0.000325	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000173	0.000323	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000172	0.000323	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000171	0.000321	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000171	0.000319	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000169	0.000316	CbGpPWpGaD
Bromocriptine—ADRA2C—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000167	0.000313	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000167	0.000312	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000167	0.000312	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000166	0.00031	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000165	0.000308	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000165	0.000308	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000164	0.000307	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000164	0.000307	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000163	0.000305	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—LPL—focal segmental glomerulosclerosis	0.000163	0.000305	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000163	0.000305	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000163	0.000304	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000162	0.000304	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000162	0.000303	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000162	0.000303	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000162	0.000303	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000162	0.000302	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00016	0.0003	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000159	0.000297	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000158	0.000296	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000156	0.000291	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000155	0.00029	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000153	0.000287	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000153	0.000287	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000152	0.000284	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000151	0.000282	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000151	0.000282	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00015	0.000281	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00015	0.000281	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00015	0.000281	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000149	0.000279	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000149	0.000278	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000148	0.000277	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000147	0.000276	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000147	0.000275	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000146	0.000274	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000146	0.000273	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000145	0.000272	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000145	0.000271	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000145	0.00027	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000144	0.000269	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000141	0.000264	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000141	0.000263	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000141	0.000263	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00014	0.000262	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00014	0.000262	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00014	0.000261	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—AGT—focal segmental glomerulosclerosis	0.00014	0.000261	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000138	0.000259	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000138	0.000259	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000138	0.000259	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000138	0.000259	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000137	0.000257	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000136	0.000255	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000136	0.000254	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000135	0.000252	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000134	0.000251	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000134	0.00025	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000133	0.000248	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	0.000133	0.000248	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000132	0.000247	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00013	0.000242	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000129	0.000242	CbGpPWpGaD
Bromocriptine—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000128	0.00024	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000128	0.000239	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000128	0.000239	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000128	0.000239	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000127	0.000238	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000126	0.000236	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000126	0.000235	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000125	0.000234	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000125	0.000234	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000125	0.000234	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000124	0.000233	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000124	0.000233	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000124	0.000232	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000123	0.00023	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000122	0.000228	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000122	0.000228	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000122	0.000228	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000121	0.000226	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00012	0.000224	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00012	0.000224	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.00012	0.000224	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000119	0.000223	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000117	0.000219	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000117	0.000218	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000117	0.000218	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000115	0.000216	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000115	0.000216	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000115	0.000215	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000114	0.000214	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000114	0.000214	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	0.000113	0.000212	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000113	0.000211	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000111	0.000208	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000111	0.000207	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000111	0.000207	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000108	0.000202	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000108	0.000202	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000108	0.000202	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—ALB—focal segmental glomerulosclerosis	0.000107	0.0002	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000106	0.000199	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000106	0.000199	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000106	0.000199	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000106	0.000198	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000106	0.000197	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000105	0.000196	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000104	0.000195	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000102	0.000192	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000102	0.000191	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	9.78e-05	0.000183	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.72e-05	0.000182	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.69e-05	0.000181	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	9.63e-05	0.00018	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.61e-05	0.00018	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.6e-05	0.000179	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.59e-05	0.000179	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.52e-05	0.000178	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	9.48e-05	0.000177	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	9.43e-05	0.000176	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.32e-05	0.000174	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.27e-05	0.000173	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	9.25e-05	0.000173	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.23e-05	0.000173	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.18e-05	0.000172	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	9.16e-05	0.000171	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	8.97e-05	0.000168	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	8.83e-05	0.000165	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	8.76e-05	0.000164	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	8.76e-05	0.000164	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	8.7e-05	0.000163	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	8.26e-05	0.000155	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	8.15e-05	0.000152	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	8.15e-05	0.000152	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	8.15e-05	0.000152	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	8.14e-05	0.000152	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	8.01e-05	0.00015	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.91e-05	0.000148	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.9e-05	0.000148	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.85e-05	0.000147	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	7.84e-05	0.000147	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	7.84e-05	0.000147	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.68e-05	0.000144	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.56e-05	0.000141	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.5e-05	0.00014	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.43e-05	0.000139	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.36e-05	0.000138	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	7.32e-05	0.000137	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	7.29e-05	0.000136	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.22e-05	0.000135	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.1e-05	0.000133	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.07e-05	0.000132	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.87e-05	0.000129	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.81e-05	0.000127	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.76e-05	0.000127	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.72e-05	0.000126	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.72e-05	0.000126	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	6.26e-05	0.000117	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.24e-05	0.000117	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.14e-05	0.000115	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.12e-05	0.000114	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.06e-05	0.000113	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	6.02e-05	0.000113	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.01e-05	0.000112	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.85e-05	0.00011	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.82e-05	0.000109	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.66e-05	0.000106	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	5.65e-05	0.000106	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.58e-05	0.000104	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.58e-05	0.000104	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.14e-05	9.61e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.06e-05	9.46e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.95e-05	9.26e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	4.83e-05	9.03e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	4.8e-05	8.98e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.6e-05	8.61e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	3.71e-05	6.93e-05	CbGpPWpGaD
